jean-claude BERTRAND | McGill University, Montréal | McGill
Brain cancer: An intelligent molecule to fool and kill glioblastoma cells | McGill University Health Centre
Anne-Laure Larroque (Lombard) - Drug Discovery Platform Research Associate - The Research Institute of the McGill University Health Centre | LinkedIn
In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N- Acetoxymethyl Carbamate-Containing Combi-Molecule
jean-claude BERTRAND | McGill University, Montréal | McGill
Dr. Bertrand J. Jean-Claude - Director at the Research Institute of the MUHC - McGill - YouTube
Leadership and Management - Research Institute of the McGill University Health Centre - RI-MUHC
jean-claude BERTRAND | McGill University, Montréal | McGill
jean-claude BERTRAND | McGill University, Montréal | McGill
jean-claude BERTRAND | McGill University, Montréal | McGill
MGMT Is a Molecular Determinant for Potency of the DNA-EGFR–Combi-Molecule ZRS1
McGill Oncology - Dr. Bertrand Jean-Claude and a team of... | Facebook
PDF) Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells
Dr Bertrand J Jean Claude - Wiki Meeting - 2018 - YouTube
Dr. Jean-Claude Bertrand - Research Grant - 2011 - Brain Tumour Foundation of Canada
McGill Oncology - Dr. Bertrand Jean-Claude and a team of... | Facebook
2012 - Faculty of Medicine - McGill University
Loop | Bertrand Jean-claude
Audrey Burban (@audrey_burban) / Twitter
Bertrand Jean-Claude | MI4 - McGill University
PDF) Optimization of novel combi-molecules: Identification of balanced and mixed bcr-abl/DNA targeting properties | James Mcnamee - Academia.edu
Biological Effects of AL622, a Molecule Rationally Designed to Release an EGFR and a câ•'Src Kinase Inhibitor
